plafibride has been researched along with Carbohydrate Inducible Hyperlipemia in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gómez, JM; Morató, J; Soler, J; Vinzia, C | 1 |
del Rio, A; Ferreira, IJ; González-Viejo, N; Vicens, B | 1 |
Casasnovas Lenguas, JA; Cornudella Lacasa, R; del Río Ligorit, A; Ferreira Montero, IJ; Gutiérrez Martín, M | 1 |
Jover, E; López, IM; Rodriguez, F | 1 |
2 trial(s) available for plafibride and Carbohydrate Inducible Hyperlipemia
Article | Year |
---|---|
Double-blind study on the activity of plafibride in the treatment of type IV hyperlipoproteinemia.
Topics: Clinical Trials as Topic; Clofibrate; Clofibric Acid; Double-Blind Method; Female; Humans; Hyperlipoproteinemia Type IV; Hypolipidemic Agents; Lipids; Male; Middle Aged; Platelet Function Tests | 1981 |
[Controlled clinical trial of a new drug (plafibride) for the treatment of hyperlipoproteinemia type IV (author's transl)].
Topics: Adult; Aged; Clinical Trials as Topic; Clofibrate; Clofibric Acid; Double-Blind Method; Female; Humans; Hyperlipoproteinemia Type IV; Lipids; Male; Middle Aged; Platelet Function Tests; Random Allocation | 1982 |
2 other study(ies) available for plafibride and Carbohydrate Inducible Hyperlipemia
Article | Year |
---|---|
[Plafibride treatment of hyperlipidemias type II and IV].
Topics: Adult; Cholesterol; Clofibrate; Clofibric Acid; Female; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Hypolipidemic Agents; Male; Middle Aged; Triglycerides | 1984 |
Plafibride treatment and serum lipids in hyperlipoproteinemias.
Topics: Adolescent; Adult; Blood Glucose; Cholesterol; Clofibrate; Clofibric Acid; Diet; Female; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Insulin; Male; Phosphatidylcholines; Triglycerides | 1987 |